Sonoma Pharmaceuticals, Inc. Common Stock
SNOASonoma Pharmaceuticals, Inc. is a healthcare company focused on developing and commercializing innovative pharmaceutical products for infection prevention and wound care. The company specializes in proprietary formulations aimed at reducing bacterial resistance and improving patient outcomes, primarily serving the eye care and wound management markets.
Company News
Ericsson reported better-than-expected Q2 sales and issued guidance, causing its shares to rise in pre-market trading. Several other stocks also saw significant pre-market movement, both positive and negative.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter. Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company rep...
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer. Lantheus Holdings shares dipped 22.5% to $58.93 on Monday. Here are some other stocks moving in today's mi...
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older. Arcutis Biotherapeutics shares gained 25.3% to $3.06 in pre-market trading. Here are some other stocks moving in p...
